CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-15 | Schuling Douglas A Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2016-06-15 | Gonyer David A Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2016-03-28 | SEYMOUR TAMARA A CFO, Secretary, Treasurer | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2016-03-28 | Riccitelli Samuel D President & CEO | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2016-02-11 | Riccitelli Samuel D President & CEO | Option exercise | +124,252 | 469,382 | ||
| 2016-02-11 | Riccitelli Samuel D President & CEO | Shares withheld for taxes | −54,268 | $0.46 | $25K | 415,114 |
| 2016-02-11 | Riccitelli Samuel D President & CEO | Option exercise · Restricted Stock Units | −124,252 | 124,251 | ||
| 2015-11-20 | Riccitelli Samuel D President & CEO | Purchase | +7,000 | $0.80 | $6K | 345,130 |
| 2015-11-19 | Riccitelli Samuel D President & CEO | Purchase | +7,000 | $0.78 | $5K | 338,130 |
Page 16 of 16 · 309 trades